The global blood plasma derivatives market is projected to observe a remarkable growth at a CAGR of 9.5% between 2020 to 2030. The market was valued USD 36. 47 bn and might reach the anticipated value of USD 89.76 bn by the end of year 2030.
The growth of this industry can be attributed to the increasing demand for the plasma derivatives in various applications such as biopharmaceutical, clinical, and medical devices & instruments.
Researchmoz shares a comprehensive insight on the market size, drivers, restraints, challenges, opportunities.
Rare Genetic Disorders Boosts the Demand for Blood Plasma Derivatives Market
The rare genetic disorder such as hemophilia and thrombotic thrombocytopenic purpura (TTP) globally are paving the way for the expansion of the global blood plasma derivatives market over the forecast years. Furthermore, an increase in research and development activities for developing new products is adding to the growth potential in the global blood plasma derivatives market.
Viral Hepatitis Drives the Blood Plasma Derivatives Market
Rising incidences of viral hepatitis globally is pushing the market to grow during the forecast period. The new changes in plasma donations are causing the market to grow as there is a less risk of any contamination and safe for the patients.
However, stringent government regulations and safety concerns related to plasma derivatives may impede the market.
Despite that, the rising investment in research and development to improve the plasma derivative will strengthen the global plasma derivatives market.
The blood plasma derivatives market will exhibit a growth rate of CAGR of 9.5% during 2020 to 2030.
The market for the blood plasma derivatives is witnessing strong growth due to a rise in prevalence of immune-related disorders, increase in research and development activities is resulting in the growth of the global blood plasma market.
The growth of this market can be attributed to the increasing prevalence of various haematological disorders, increasing demand for plasma derived drugs, and technological advancements in the pharmaceutical industry.
North America will hold a highest share in the blood plasma derivatives market during the forecast period. The market in this region is majorly driven by rising elderly population. Additionally, growing prevalence of chronic diseases and increasing R&D investments are some of the other factors fueling the demand for blood plasma derivatives market.
ResearchMoz published a comprehensive research report on the blood plasma derivatives market so that the stakeholders can strategic decision to succeed in this space.
The prominent players of the global blood plasma derivatives market include-
- Kedrion S.p.A
- LFB S.A.
- Bain Capital
- LLC and Biotest AG.
- Grifols, S.A.
- Baxter International Inc.
- CSL Limited
- Octapharma AG
ResearchMoz shares a detailed report covering in depth analysis of the global blood plasma derivatives market.
Bovine blood plasma and its derivatives is used in various medical and research applications, leading to the growth of the blood plasma derivatives market during the forecast years.
Increasing prevalence of cardiovascular disorders such as chronic atherosclerosis, acute coronary syndrome, and others is also driving the growth of this market.
Growing demand for albumin products is expected to drive the global blood plasma derivatives market.
- Intravenous immunoglobulin (IVIG)
- Fresh Frozen Plasma (FFP)
- Factor VIII
- Factor IX
- Hemophilia A
- Hemophilia B
- Von Willebrand Disease
- South Korea